Speeding up the translation from bench to bedside
Objective:
Improve the translational approach in research to increase the number of new treatments and prevention strategies that will become available in health care for OA patients.
Task 2.1: Technical and economic hurdles associated with the establishment and implementation of translational research models (crossing the Valley of Death).
Task 2.2: Guidelines for data collection, sampling, phenotyping, endotyping and clinical trial designs for companies bringing products targeting OA to the market to avoid common repeated failures in phase 2 and 3 clinical trials.
Task 2.3: Identification of the major challenges associated with translation from preclinical models to humans without intermediate translational models.
Task 2.4: European Consensus on Chronic Disease Self-Management Program CDSMP program for OA prevention.
Deliverables
On the 24th of October, at 11am CET WEST, we had the WG2 Monthly Meeting, that took place online.
During the meeting we discussed the work being developed, including the progress of the different manuscripts and the planning of the Podcast series. Some of the manuscripts are approaching final revisions before submission and the Podcast series is expected to start recordings in November, so stay tuned for fresh news on WG2 activities!
Finally, the short-term scientific missions involving our WG, new project ideas and potential for collaborations with other WGs were discussed.